I now have rich, authoritative content from Harrison's (2025), Goldman-Cecil Medicine, and Brenner & Rector's Kidney. Let me compile the comprehensive introduction to dialysis.
Introduction to Dialysis
1. Definition and Overview
Dialysis is a life-sustaining renal replacement therapy (RRT) that artificially performs the filtration functions of failed kidneys - removing nitrogenous waste products, excess solutes, and fluid from the blood. The word comes from the Greek dialusis (separation through). It is indicated when the kidneys can no longer maintain homeostasis adequately.
"Dialysis may be required for the treatment of either acute or chronic kidney disease."
- Harrison's Principles of Internal Medicine, 22nd Edition (2025)
2. When Is Dialysis Needed?
Indications for Starting Dialysis
Dialysis is typically initiated when the estimated glomerular filtration rate (eGFR) falls below 10 mL/min/1.73 m², though it may be needed at eGFR 10-15 mL/min if comorbidities (especially heart failure) make medical management difficult. Clinical indications (not just a number) drive the decision.
| Indication | Detail |
|---|
| Uremic encephalopathy or neuropathy | CNS/PNS manifestations of uremia |
| Pericarditis or pleuritis | Uremic serositis |
| Uremic bleeding | Platelet dysfunction |
| Fluid overload refractory to diuretics | Volume overload |
| Uncontrolled hypertension | Refractory to medications |
| Persistent hyperkalemia | Life-threatening arrhythmia risk |
| Metabolic acidosis | Refractory to bicarbonate therapy |
| Malnutrition / weight loss | Uremic anorexia |
| Persistent nausea and vomiting | Uremic gastropathy |
(Table adapted from Goldman-Cecil Medicine, International Edition)
3. Epidemiology
- In the United States, over 800,000 patients have treated ESKD (end-stage kidney disease), the vast majority requiring dialysis.
- Since 2000, prevalence of treated ESKD in the US has risen 65%, mostly reflecting improved dialysis survival.
- The crude incidence is approximately 363 cases per million population per year in the US.
- Leading cause of ESKD: diabetes mellitus (~45%), followed by hypertension (~30%), glomerulonephritis, polycystic kidney disease.
- Globally, prevalence is highest in Taiwan (3170 pmp), Japan (2620 pmp), and the United States (2080 pmp).
- Deaths on dialysis are mainly from cardiovascular disease and infections.
(Harrison's Principles of Internal Medicine, 22nd Ed., 2025)
4. Physiological Principles of Dialysis
Dialysis works through two fundamental transport mechanisms:
A. Diffusion
Solutes move along their concentration gradients across a semipermeable membrane from blood to dialysate. This removes:
- Urea, creatinine, uric acid (uremic toxins)
- Excess potassium, phosphate
- Corrects metabolic acidosis (via bicarbonate in dialysate)
B. Convection (Ultrafiltration)
Plasma water is driven across the membrane by a pressure gradient, dragging dissolved solutes with it (solvent drag). This removes excess fluid (edema, hypertension).
- In hemodialysis: driven by hydrostatic pressure applied across the artificial membrane
- In peritoneal dialysis: driven by an oncotic gradient using high-dextrose or large carbohydrate polymers in dialysate
Dialysate Composition
Dialysate is intentionally non-physiologic to promote correction:
- Potassium: ~2 mEq/L (lower than plasma) to remove excess K⁺
- Bicarbonate: ~35 mEq/L (higher than plasma) to correct acidosis
- Prepared by reverse osmosis + deionization to remove trace minerals, bacteria, and endotoxins
5. Types of Dialysis
A. Hemodialysis (HD)
Blood is pumped outside the body through an artificial kidney (dialyzer) containing a synthetic semipermeable membrane, then returned to the patient.
Modalities:
| Type | Setting | Frequency | Duration |
|---|
| Conventional in-center HD | Dialysis unit / hospital | 3×/week | 3-4 hours/session |
| Home HD | Patient's home | 3-6×/week | Variable |
| Nocturnal HD | Home / center | 6×/week (overnight) | 6-8 hours |
| CRRT (Continuous RRT) | ICU only | Continuous | 24 hrs/day |
| PIRRT / SLED (Slow Low-Efficiency Dialysis) | ICU | Daily or alternating | 6-12 hrs/session |
Vascular Access (the "lifeline" of hemodialysis):
- Arteriovenous Fistula (AVF) - preferred; native vein anastomosed to artery (e.g., radiocephalic, brachiocephalic)
- Arteriovenous Graft (AVG) - synthetic conduit connecting artery to vein
- Central Venous Catheter (CVC) - temporary or tunneled; highest infection risk
Dialysis Adequacy:
- Measured by Urea Reduction Ratio (URR): target ≥65% per session
- Or by spKt/V (single-pool normalized urea clearance): target ≥1.2 on thrice-weekly schedule
- Increasing frequency (6×/week) improves blood pressure, left ventricular hypertrophy regression, and phosphorus control
B. Peritoneal Dialysis (PD)
Uses the patient's own peritoneal membrane (a natural biologic membrane lining the abdominal cavity) as the dialysis membrane. Dialysate is instilled into the peritoneal cavity via a surgically placed catheter.
Modalities:
| Type | Description |
|---|
| CAPD (Continuous Ambulatory PD) | Manual exchanges ~4×/day; no machine needed |
| CCPD (Continuous Cyclic PD) | Automated cycler performs exchanges at night |
Key Features:
- Ongoing, gentle, continuous clearance (vs. intermittent HD)
- Small molecules (urea, creatinine) are cleared less efficiently than HD per unit time
- Better preservation of residual kidney function early on
- Preferred for: hemodynamic instability, remote locations, patient preference for independence
Mechanism: High-dextrose dialysate creates an osmotic gradient, drawing fluid across the peritoneal membrane.
C. Continuous Renal Replacement Therapy (CRRT)
Used exclusively in hemodynamically unstable ICU patients. Blood flows at 150-300 mL/min through a highly permeable membrane, continuously removing water and solutes up to ~60 kDa by convection. Avoids the hemodynamic stress of intermittent HD.
6. Treatment Modality Selection
| Factor | Favors HD | Favors PD |
|---|
| Hemodynamic stability | Unstable → CRRT/SLED | Stable → PD acceptable |
| Vascular access | AVF available | No suitable vascular access |
| Abdominal surgery history | Preferred | Adhesions may prevent PD |
| Patient preference | In-center care | Home independence |
| Residual kidney function | Either | PD preserves better |
| Body size (large) | HD may be more adequate | Less efficient in large patients |
| Visual/dexterity impairment | Center HD | Difficult to self-manage PD |
As stated in Harrison's 22nd Ed.: "In ESKD, treatment options include hemodialysis (in a center or at home); peritoneal dialysis, as either CAPD or CCPD; or transplantation."
7. Complications of Dialysis
Hemodialysis Complications
- Hypotension (most common intradialytic complication) - due to rapid fluid removal
- Access problems: thrombosis, stenosis, infection, inadequate flow
- Cardiovascular: LV hypertrophy, arrhythmias, pericarditis
- Infections: bacteremia (especially with CVC access)
- Dialysis disequilibrium syndrome: rapid osmotic shifts causing cerebral edema (especially first sessions)
- Anemia, renal osteodystrophy, amyloidosis (β2-microglobulin accumulation - long-term)
- Chronic inflammation: exposure to impurities in dialysate
Peritoneal Dialysis Complications
- Peritonitis: most common complication - usually gram-positive organisms from skin flora
- Catheter-related infections (exit site, tunnel infections)
- Inadequate ultrafiltration: membrane failure over time
- Hernias, hydrothorax: pressure-related
- Metabolic: hyperglycemia (from dextrose), hypertriglyceridemia, protein loss
8. Outcomes and Prognosis
- Dialysis does not cure CKD; it maintains life until transplantation or death
- Kidney transplantation is superior to dialysis in all eligible patients - better survival, quality of life, and cost-effectiveness
- The 5-year survival of patients on dialysis in developed countries is approximately 35-40%
- Cardiovascular disease remains the leading cause of death in dialysis patients
- More frequent dialysis (nocturnal HD 6×/week) has shown 46% mortality reduction at median 3.6-year follow-up compared to conventional thrice-weekly HD
9. Recent Evidence (2024-2025)
A comprehensive 2024
JAMA review by Flythe & Watnick (
Dialysis for Chronic Kidney Failure, JAMA 2024) provides an updated synthesis of dialysis management for CKD, highlighting individualized decision-making, timing of initiation (guided by symptoms rather than eGFR alone), and interprofessional care to address cardiovascular risk - the leading cause of mortality in dialysis patients.
Summary
Dialysis is the cornerstone of RRT for kidney failure, working through diffusion and convection to replicate excretory kidney function. The two primary modalities - hemodialysis (machine-based, extracorporeal) and peritoneal dialysis (membrane-based, intraperitoneal) - have different indications, advantages, and complications. Choice of modality is individualized based on clinical, anatomical, and patient-preference factors. While life-sustaining, dialysis carries significant morbidity and mortality; renal transplantation remains the optimal long-term therapy where possible.
Key Sources:
- Harrison's Principles of Internal Medicine, 22nd Edition (2025), Chapter 323
- Goldman-Cecil Medicine, International Edition, Chapter 117 (Table 117-1)
- Brenner and Rector's The Kidney - Chapters 81, 96
- Comprehensive Clinical Nephrology, 7th Edition
- Flythe JE & Watnick S. Dialysis for Chronic Kidney Failure: A Review. JAMA. 2024 Nov 12. PMID: 39356511